06feb2024
Preliminary Results as of 31 December 2023
Board of Directors meeting to approve the preliminary results as of December 31st, 2023.
The examination and publication dates of economic and financial results
07feb2024
Capital Markets Day
Capital Markets Day
21mar2024
Approval of the Draft Financial Statements as of 31 December 2023
Board of Directors meeting to approve the Consolidated Financial Statements as of December 31st, 2023 and the draft of the Annual Report as of December 31st, 2023.
29apr2024
Annual Shareholders’ Meeting
Shareholders’ Meeting to approve the Company’s financial statements as of December 31st, 2023.
15mag2024
Quarterly Report as of 31 March 2024
Board of Directors meeting to approve selected information related to business performance for the first quarter of 2024(*) (Revenues; EBITDA; Backlog; Net Financial Position) and related press release containing quarterly information. (*) Information not subject to audit, not even limited.
10set2024
Half-Yearly Report as of 30 June 2024
Board of Directors meeting to approve the Consolidated half-yearly Financial Report as of June 30th, 2024.
12nov2024
Quarterly Report as of 30 September 2024
Board of Directors meeting to approve indicative selected information related to business performance for the third quarter of 2024(*) (Revenues; EBITDA; Backlog; Net Financial Position) and related press release containing quarterly information. (*) Information not subject to audit, not even limited.
24gen2023
Preliminary Financial Results as at 31 December 2022 and Capital Markets Day
Board of Directors Meeting to approve preliminary results as at 31 December 2022; Capital Markets Day – strategy update and economic and financial outlook.
21mar2023
Approval of the Draft Financial Report as at 31 December 2022
Meeting of the Board of Directors to approve the draft Financial Report as at 31 December 2022.
27apr2023
Ordinary Shareholders’ Meeting
Shareholders’ Meeting to approve the Financial Report as at 31 December 2022.
10mag2023
Quarterly Report as at 31 March 2023
Board of Directors Meeting to approve the selected information indicative of the business performance for the first quarter of 2023(*)(Revenues; EBITDA; Backlog; Net Financial Position) and the related press release including the quarterly information. (*) Information not subject to audit, not even limited.
07set2023
Half-Year Report as at 30 June 2023
Board of Directors Meeting to approve the Half-Year Financial Report as at 30 June 2023.
07nov2023
Quarterly Report as at 30 September 2023
• Board of Directors Meeting to approve the selected information indicative of the business performance for the third quarter of 2023(*)(Revenues; EBITDA; Backlog; Net Financial Position) and the related press release including the quarterly information. (*) Information not subject to audit, not even limited.
24mar2022
Approval of the Draft Financial Statements at December 31st 2021
Meeting of the Board of Directors to approve the draft Financial Statements at December 31st, 2021.
29apr2022
Shareholders’ Meeting
Shareholders' Meeting to approve the Financial Statements at December 31st , 2021
11mag2022
Quarterly Report at March 31st, 2022
Meeting of the Board of Directors to approve the selected information indicative of the performance of the business for the first quarter of 2022(*) (Production value; EBITDA; Backlog; Net Financial Position) and the related press release containing the quarterly information. (*) Information not subject to revision, not even limited
04ago2022
Preliminary financial data as at June 30th, 2022
Meeting of the Board of Directors for approval of preliminary financial data at June 30th, 2022.
22feb2022
Preliminary financial data as at December 31st, 2021 and Guidance 2022
Meeting of the Board of Directors for approval of preliminary financial data as at December 31st, 2021 and Guidance 2022.
13set2022
Half-Year Financial Statements at June 30th, 2022
Board of Directors for the approval of Half-Year Financial Statements at June 30th, 2022.
10nov2022
Quarterly Report at September 30th, 2022
Meeting of the Board of Directors to approve the selected information indicative of the performance of the business for the third quarter of 2022(*) (Production value; EBITDA; Backlog; Net Financial Position) and the related press release containing the quarterly information. (*) Information not subject to revision, not even limited.
15set2021
Half-Year Financial Statements at June 30th, 2021
Board of Directors for the approval of Half-Year Financial Statements at June 30th, 2021.
15nov2021
Quarterly Report at September 30th, 2021
Board of Directors for the approval of the press release containing a quarterly reporting with selected information reflective of the development of the business related to the third quarter of 2021(*) (Production Value; EBITDA; Backlog; Net Financial Position). (*) Information not subject to revision, not even limited.
